VistaGen Therapeutics Aktie
WKN DE: A2AJU8 / ISIN: US92840H2022
08.08.2025 01:17:22
|
VistaGen Therapeutics Inc Q1 Sales Increase
(RTTNews) - VistaGen Therapeutics Inc (VTGN) announced Loss for first quarter of -$15.10 million
The company's bottom line came in at -$15.10 million, or -$0.47 per share. This compares with -$10,73 million, or -$0.35 per share, last year.
The company's revenue for the period rose 200% to $0.24 million from $0.08 million last year.
VistaGen Therapeutics Inc earnings at a glance (GAAP) :
-Earnings: -$15.10 Mln. vs. -$10,73 Mln. last year. -EPS: -$0.47 vs. -$0.35 last year. -Revenue: $0.24 Mln vs. $0.08 Mln last year.

Wenn Sie mehr über das Thema Aktien erfahren wollen, finden Sie in unserem Ratgeber viele interessante Artikel dazu!
Jetzt informieren!
Nachrichten zu VistaGen Therapeutics Incmehr Nachrichten
Keine Nachrichten verfügbar. |